Birdwatch Note
2024-07-04 16:55:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Das ist eine Fehldarstellung: Nach Ausbruch der COVID-19-Pandemie konnte "Roche", nicht Drosten, einen ersten PCR-Test auf den Markt bringen, um eine aktive Infektion mit SARS-CoV-2 nachzuweisen. Der Test erhielt Mitte März 2020 die Notfallzulassung der US-Zulassungsbehörde. https://www.roche.de/unternehmen/stories/brillant-unkonventionell-und-umstritten-kary-mullis-erfinder-der-pcr-technologie#:~:text=Mit%20der%20Entscheidung%20für%20den,sie%20nur%20in%20Laboren%20bekannt.
Written by AE392472D289E0D7728EED0EBDCEDCA116B415EC3052769023B05753E2F134F2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1808734559099343233
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1808907591562453250
- noteId - 1808907591562453250
- participantId -
- noteAuthorParticipantId - AE392472D289E0D7728EED0EBDCEDCA116B415EC3052769023B05753E2F134F2 Participant Details
- createdAtMillis - 1720112152364
- tweetId - 1808734559099343233
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Das ist eine Fehldarstellung: Nach Ausbruch der COVID-19-Pandemie konnte "Roche", nicht Drosten, einen ersten PCR-Test auf den Markt bringen, um eine aktive Infektion mit SARS-CoV-2 nachzuweisen. Der Test erhielt Mitte März 2020 die Notfallzulassung der US-Zulassungsbehörde. https://www.roche.de/unternehmen/stories/brillant-unkonventionell-und-umstritten-kary-mullis-erfinder-der-pcr-technologie#:~:text=Mit%20der%20Entscheidung%20für%20den,sie%20nur%20in%20Laboren%20bekannt.
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-07-04 16:55:52 UTC (1720112152364) |
2024-07-06 11:20:49 UTC (1720264849819) |
CURRENTLY_RATED_HELPFUL | 2024-07-14 02:45:42 UTC (1720925142742) |
NEEDS_MORE_RATINGS | 2024-07-06 11:20:49 UTC (1720264849819) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-07-07 05:41:39 -0500 | Rating Details | |
2024-07-07 00:42:41 -0500 | Rating Details | |
2024-07-06 13:36:29 -0500 | Rating Details | |
2024-07-06 13:27:39 -0500 | Rating Details | |
2024-07-06 11:50:14 -0500 | Rating Details | |
2024-07-06 11:13:06 -0500 | Rating Details | |
2024-07-06 08:09:52 -0500 | Rating Details | |
2024-07-06 07:40:38 -0500 | Rating Details | |
2024-07-06 07:15:47 -0500 | Rating Details | |
2024-07-06 07:09:50 -0500 | Rating Details | |
2024-07-06 06:12:04 -0500 | Rating Details | |
2024-07-06 05:53:09 -0500 | Rating Details | |
2024-07-06 05:45:25 -0500 | Rating Details | |
2024-07-06 05:09:44 -0500 | Rating Details | |
2024-07-06 04:46:00 -0500 | Rating Details | |
2024-07-06 04:11:11 -0500 | Rating Details | |
2024-07-06 04:08:17 -0500 | Rating Details | |
2024-07-06 04:05:21 -0500 | Rating Details | |
2024-07-06 03:51:05 -0500 | Rating Details | |
2024-07-06 03:31:31 -0500 | Rating Details | |
2024-07-06 03:01:03 -0500 | Rating Details | |
2024-07-06 02:43:31 -0500 | Rating Details | |
2024-07-06 02:19:38 -0500 | Rating Details | |
2024-07-06 02:14:38 -0500 | Rating Details | |
2024-07-06 02:11:35 -0500 | Rating Details | |
2024-07-06 02:05:53 -0500 | Rating Details | |
2024-07-06 01:58:43 -0500 | Rating Details | |
2024-07-06 01:46:05 -0500 | Rating Details | |
2024-07-06 01:43:26 -0500 | Rating Details | |
2024-07-06 01:29:37 -0500 | Rating Details | |
2024-07-06 01:20:32 -0500 | Rating Details | |
2024-07-06 01:12:03 -0500 | Rating Details | |
2024-07-05 16:05:13 -0500 | Rating Details | |
2024-07-05 15:43:07 -0500 | Rating Details | |
2024-07-05 11:58:28 -0500 | Rating Details | |
2024-07-05 03:42:51 -0500 | Rating Details | |
2024-07-05 01:38:43 -0500 | Rating Details | |
2024-07-05 00:56:37 -0500 | Rating Details | |
2024-07-04 20:03:32 -0500 | Rating Details | |
2024-07-04 17:20:23 -0500 | Rating Details | |
2024-07-04 16:28:05 -0500 | Rating Details | |
2024-07-04 16:08:53 -0500 | Rating Details | |
2024-07-04 15:33:01 -0500 | Rating Details | |
2024-07-04 15:27:52 -0500 | Rating Details | |
2024-07-04 14:49:08 -0500 | Rating Details | |
2024-07-04 13:37:39 -0500 | Rating Details | |
2024-07-04 13:25:07 -0500 | Rating Details |